AYTU BIOPHARMA, INC Quarterly Return On Assets in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aytu Biopharma, Inc quarterly/annual Return On Assets history and growth rate from Q2 2012 to Q2 2024.
  • Aytu Biopharma, Inc Return On Assets for the quarter ending June 30, 2024 was -12.4 %, a 4.55% decline year-over-year.
  • Aytu Biopharma, Inc annual Return On Assets for 2024 was -12.4 %, a 4.55% decline from 2023.
  • Aytu Biopharma, Inc annual Return On Assets for 2023 was -11.9 %, a 79.3% increase from 2022.
  • Aytu Biopharma, Inc annual Return On Assets for 2022 was -57.4 %, a 108% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -12.4 -0.54 -4.55% Apr 1, 2024 Jun 30, 2024
Q1 2024 -10.3 +11 +51.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -13.1 +38.2 +74.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -17.5 +30.5 +63.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -11.9 +45.5 +79.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -21.3 +29.1 +57.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -51.4 -17.4 -51.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48 -12.9 -36.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.4 -29.8 -108% Apr 1, 2022 Jun 30, 2022
Q1 2022 -50.4 -27.3 -118% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.9 -19.5 -136% Oct 1, 2021 Dec 31, 2021
Q3 2021 -35.1 -25.3 -257% Jul 1, 2021 Sep 30, 2021
Q2 2021 -27.6 -14.5 -111% Apr 1, 2021 Jun 30, 2021
Q1 2021 -23.2 +10.3 +30.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -14.4 +39.8 +73.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -9.85 +68.3 +87.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -13 +68.3 +84% Apr 1, 2020 Jun 30, 2020
Q1 2020 -33.4 +6.81 +16.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -54.2 -14.6 -36.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -78.1 -31.9 -69.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -81.3 -33.1 -68.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -40.3 +48.9 +54.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -39.6 +72.4 +64.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -46.2 +68 +59.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -48.2 +85.3 +63.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -89.1 +72.7 +44.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -112 +47.9 +30% Oct 1, 2017 Dec 31, 2017
Q3 2017 -114 +33.4 +22.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -134 -11.2 -9.11% Apr 1, 2017 Jun 30, 2017
Q1 2017 -162 -91.8 -131% Jan 1, 2017 Mar 31, 2017
Q4 2016 -160 -108 -209% Oct 1, 2016 Dec 31, 2016
Q3 2016 -148 -84.1 -133% Jul 1, 2016 Sep 30, 2016
Q2 2016 -122 -13.6 -12.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -70 +30.4 +30.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -51.8 +128 +71.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -63.5 +63.3 +49.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -109 -51.6 -90.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -100 +21.5K +99.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -180 +368 +67.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -127 +393 +75.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -57.1 +493 +89.6% Mar 1, 2014 May 31, 2014
Q1 2014 -21.6K -21.1K -4292% Jan 1, 2014 Mar 31, 2014
Q4 2013 -548 -111 -25.5% Sep 1, 2013 Nov 30, 2013
Q3 2013 -520 -519 -40983% Jun 1, 2013 Aug 31, 2013
Q2 2013 -550 -549 -50558% Mar 1, 2013 May 31, 2013
Q1 2013 -491 Dec 1, 2012 Feb 28, 2013
Q4 2012 -437 Sep 1, 2012 Nov 30, 2012
Q3 2012 -1.27 Jun 1, 2012 Aug 31, 2012
Q2 2012 -1.09 Mar 1, 2012 May 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.